In 1989, the European NIDDM Policy Group (Type 2 diabetes) suggested HbA 1 was good <8.5%, acceptable 8.5�9.5%, poor >9.5% (equivalent to HbA 1c of <6.9, 6.9�7.7, >7.7%). No ev idence for these limits was given, and it was not clear whether the intent was for micro- or macrovascular protection or both. However, the need to individualise by life expectancy was acknowledged 114
---
 nice.evidencecategory: IV
[@Alberti_1988]
